Hebei Changshan Biochem Pharma (300255) — Long-term Investment Intensity
Hebei Changshan Biochem Pharma (300255) has a Long-term Investment Intensity of 0.2% as of September 2019. Long-term investments of CN¥9.45 Million represent 0.2% of total assets of CN¥4.04 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check how resilient are Hebei Changshan Biochem Pharma's assets to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Hebei Changshan Biochem Pharma Long-term Investment Intensity (2016–2018)
This chart shows how Hebei Changshan Biochem Pharma's Long-term Investment Intensity has evolved across 3 annual periods from 2016 to 2018. As of September 2019, the intensity stands at 0.2%, reflecting long-term investments of CN¥9.45 Million against total assets of CN¥4.04 Billion CNY. For the complete balance sheet picture, see total assets of Hebei Changshan Biochem Pharma.
Annual Long-term Investment Intensity for Hebei Changshan Biochem Pharma (2016–2018)
The table below presents the year-by-year Long-term Investment Intensity for Hebei Changshan Biochem Pharma from 2016 to 2018, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read debt load of Hebei Changshan Biochem Pharma for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (CNY) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 0.2% | CN¥8.20 Million | CN¥3.84 Billion | ▼ -0.4 pp |
| 2017 | 0.6% | CN¥22.26 Million | CN¥3.53 Billion | ▼ -1.4 pp |
| 2016 | 2.1% | CN¥64.55 Million | CN¥3.13 Billion | — |